A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

Clinical trial NCT06168812 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06168812
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreatic Carcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Metastatic Metastatic Pancreatic Cancer Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2023-12-05
Primary completion: 2026-12-05
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.